Isolation of an ampicillin-resistant, non-beta-lactamase-producing strain of Haemophilus influenzae.

Antimicrobial Agents and Chemotherapy
S M Markowitz

Abstract

A 79-year-old female developed endocarditis and meningitis due to an ampicillin-resistant, non-beta-lactamase-producing strain of Haemophilus influenzae. Carbenicillin and gentamicin therapy resulted in bacteriological and clinical cure. The mechanism of resistance of ampicillin-resistant, non-beta-lactamase-producing strains of H. influenzae is unknown.

References

Feb 1, 1975·The American Journal of Medicine·C S BryanR E Bryant
Jul 25, 1977·JAMA : the Journal of the American Medical Association·E D EverettT R McNitt
Feb 1, 1978·Antimicrobial Agents and Chemotherapy·J H Jorgensen, G A Alexander
Mar 1, 1977·Medicine·C J ChunnD N Gilbert
Jan 1, 1976·Antimicrobial Agents and Chemotherapy·C ThornsberryJ M Swenson
Apr 1, 1972·Antimicrobial Agents and Chemotherapy·C H O'CallaghanA H Shingler
Jul 15, 1974·JAMA : the Journal of the American Medical Association·W KhanA K Saz
Nov 1, 1974·Antimicrobial Agents and Chemotherapy·C Thornsberry, L A Kirven
Nov 1, 1974·Antimicrobial Agents and Chemotherapy·C Thornsberry, L A Kirven
Jul 1, 1974·Antimicrobial Agents and Chemotherapy·R C GordonW H Carlson

❮ Previous
Next ❯

Citations

Sep 1, 1985·European Journal of Pediatrics·D MoulinG Wauters
Apr 28, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H Dabernat, C Delmas
Feb 1, 1986·Diagnostic Microbiology and Infectious Disease·G V DoernD A Preston
Feb 1, 2002·Diagnostic Microbiology and Infectious Disease·James A KarlowskyDaniel F Sahm
Jan 4, 2001·International Journal of Antimicrobial Agents·A Marchese, G C Schito
Oct 30, 1986·The New England Journal of Medicine
Apr 23, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Keiko HasegawaKimiko Ubukata
Jul 1, 1995·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·F W Goldstein, J F Acar
Sep 29, 2006·The Pediatric Infectious Disease Journal·Angela B Brueggemann
Jun 29, 2007·The Pediatric Infectious Disease Journal·Rita CardinesMarina Cerquetti
Aug 1, 1984·Antimicrobial Agents and Chemotherapy·P M MendelmanA L Smith
Aug 1, 1985·Antimicrobial Agents and Chemotherapy·M G Bergeron, G Y Lavoie
Apr 13, 2007·Clinical Microbiology Reviews·Stephen TristramPeter C Appelbaum
Jul 1, 1982·Archives of Disease in Childhood·J PfenningerU Zellweger
Jul 1, 1988·Journal of Clinical Pathology·M Powell, J D Williams
Apr 4, 2003·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Kenji SuzukiShunkichi Baba
Jun 20, 2007·Scandinavian Journal of Infectious Diseases·Shigeki NakamuraShigeru Kohno
Nov 1, 1987·Mayo Clinic Proceedings·K H Rhodes, C M Johnson
Feb 4, 2012·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Liang QinHiroshi Watanabe
Aug 28, 2007·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Minako AokiNaomi Kondo
Aug 18, 2004·Pediatrics International : Official Journal of the Japan Pediatric Society·Luong Dong CaoKohno Yoichi
May 17, 2011·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Niels Nørskov-LauritsenKurt Fuursted
Jun 24, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Gen SugitaNoboru Yamanaka
Apr 1, 1981·Annals of Neurology·W E Bell
May 16, 2015·Journal of Medical Microbiology·Rita CardinesMarina Cerquetti
Feb 6, 2008·FEMS Microbiology Reviews·André ZapunThierry Vernet
Feb 13, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D TalonJ M Estavoyer

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.